Professor, Executive body of the Research Council, KU Leuven (Belgium)
Team Leader, Cancer Research Center Marseille & Institut Paoli-Calmettes (France)

​

Pascale Zimmermann earned her PhD in Pharmacy from the Christian de Duve Institute at U.C.L (Belgium). She has made key contributions to understanding the molecular mechanisms governing EV biogenesis, cargo loading, uptake, and signaling. Her work has been recognized with the Royal Academy of Medicine of Belgium Award and the EMBO Young Investigator Program. Her research explores the roles of syndecans and PDZ-domain proteins—particularly syntenin—in extracellular vesicle (EV) biology.

​

Her team currently focuses on:
• clarifying the roles of proteases and heparan sulfate modifiers in EV biology;
• advancing pharmacological inhibitors of syntenin for cancer therapy;
• developing rational, biosynthetic strategies to engineer EV functional and therapeutic properties.

​

She contributes to strategic initiatives in Belgium and France to advance EV science, education and biomedical applications. She currently serves has Editor-in-Chief of the Journal of Extracellular Vesicles, the flagship journal of the International Society for Extracellular Vesicles (ISEV).